• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

From prognostication to precision in acute myeloid leukemia.

作者信息

Hourigan Christopher S

机构信息

Fralin Biomedical Research Institute.

出版信息

Blood. 2025 May 8;145(19):2105-2106. doi: 10.1182/blood.2024028105.

DOI:10.1182/blood.2024028105
PMID:40338575
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12105717/
Abstract
摘要

相似文献

1
From prognostication to precision in acute myeloid leukemia.从急性髓系白血病的预后判断到精准治疗
Blood. 2025 May 8;145(19):2105-2106. doi: 10.1182/blood.2024028105.
2
REGAL: galinpepimut-S vs. best available therapy as maintenance therapy for acute myeloid leukemia in second remission.REGAL研究：galinpepimut-S与最佳可用疗法作为急性髓系白血病第二次缓解期维持治疗的比较。
Future Oncol. 2025 Jan;21(1):73-81. doi: 10.1080/14796694.2024.2433935. Epub 2024 Nov 28.
3
Associated Familial Acute Myeloid Leukemia (AML)伴发的家族性急性髓系白血病（AML）
4
Cytarabine Pharmacogenomics and Outcomes Among Children and Young Adults With Acute Myeloid Leukemia.阿糖胞苷的药物基因组学与急性髓系白血病儿童及青年患者的预后
JAMA Netw Open. 2025 Jun 2;8(6):e2516296. doi: 10.1001/jamanetworkopen.2025.16296.
5
Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the European Hematology Association.接受新型靶向治疗的成年急性髓系白血病患者的抗真菌预防：欧洲血液学协会的系统评价和专家共识推荐
Lancet Haematol. 2022 May;9(5):e361-e373. doi: 10.1016/S2352-3026(22)00073-4.
6
Indirect treatment comparison of ivosidenib and other therapies in patients with newly diagnosed acute myeloid leukemia.ivosidenib与其他疗法在新诊断急性髓系白血病患者中的间接治疗比较。
Future Oncol. 2025 Jul;21(17):2225-2235. doi: 10.1080/14796694.2025.2515778. Epub 2025 Jun 10.
7
Multiple small bowel perforations due to invasive aspergillosis in a patient with acute myeloid leukemia: case report and a systematic review of the literature.患者因侵袭性曲霉病导致多处小肠穿孔：病例报告及文献系统回顾。
Infection. 2018 Jun;46(3):317-324. doi: 10.1007/s15010-018-1115-7. Epub 2018 Jan 22.
8
[Bioinformatic analysis of venetoclax sensitivity and resistance mechanisms in acute myeloid leukemia].[急性髓系白血病中维奈托克敏感性和耐药机制的生物信息学分析]
Zhonghua Xue Ye Xue Za Zhi. 2025 May 14;46(5):460-467. doi: 10.3760/cma.j.cn121090-20250114-00028.
9
The Role of CPX-351 in the Acute Myeloid Leukemia Treatment Landscape: Mechanism of Action, Efficacy, and Safety.CPX-351在急性髓系白血病治疗格局中的作用：作用机制、疗效与安全性
Drugs. 2025 May 10. doi: 10.1007/s40265-025-02194-w.
10
Advancing the pathway to allogeneic hematopoietic stem cell transplantation through a physician-nurse coordinator system in patients with acute leukemia.通过医师-护士协调员系统推进急性白血病患者异基因造血干细胞移植的进程。
Sci Rep. 2025 Jul 5;15(1):24089. doi: 10.1038/s41598-025-10061-7.

本文引用的文献

1
Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD-mutated AML.FLT3-ITD突变型急性髓系白血病患者的可测量残留病与移植后吉瑞替尼维持治疗
Blood. 2025 May 8;145(19):2138-2148. doi: 10.1182/blood.2024025154.
2
Measurable residual FLT3 tyrosine kinase domain mutations before allogeneic transplant for acute myeloid leukemia.急性髓系白血病异基因移植前可测量的残留FLT3酪氨酸激酶结构域突变
Bone Marrow Transplant. 2025 Feb;60(2):175-177. doi: 10.1038/s41409-024-02444-7. Epub 2024 Oct 18.
3
Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia.急性髓系白血病患者接受异基因移植前可测量的 FLT3 内串联重复。
JAMA Oncol. 2024 Aug 1;10(8):1104-1110. doi: 10.1001/jamaoncol.2024.0985.
4
Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of .吉特替尼作为伴有. 内部串联重复突变的 AML 移植后维持治疗。
J Clin Oncol. 2024 May 20;42(15):1766-1775. doi: 10.1200/JCO.23.02474. Epub 2024 Mar 12.
5
DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant.DNA 测序检测造血细胞移植前急性髓系白血病成人患者的残留疾病。
JAMA. 2023 Mar 7;329(9):745-755. doi: 10.1001/jama.2023.1363.
6
Prognostic Value of -Internal Tandem Duplication Residual Disease in Acute Myeloid Leukemia.急性髓系白血病中-串联重复残留病的预后价值。
J Clin Oncol. 2023 Feb 1;41(4):756-765. doi: 10.1200/JCO.22.00715. Epub 2022 Oct 31.
7
Pretransplant FLT3-ITD MRD assessed by high-sensitivity PCR-NGS determines posttransplant clinical outcome.通过高灵敏度聚合酶链反应-下一代测序评估的移植前FLT3-ITD微小残留病可确定移植后的临床结局。
Blood. 2022 Dec 1;140(22):2407-2411. doi: 10.1182/blood.2022016567.
8
Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With -Internal Tandem Duplication Mutation (SORMAIN).异基因造血干细胞移植治疗伴有内部串联重复突变的急性髓系白血病后的索拉非尼维持治疗（SORMAIN）。
J Clin Oncol. 2020 Sep 10;38(26):2993-3002. doi: 10.1200/JCO.19.03345. Epub 2020 Jul 16.
9
Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease.有残留疾病基因组证据的急性髓细胞性白血病异体移植的条件强度的影响。
J Clin Oncol. 2020 Apr 20;38(12):1273-1283. doi: 10.1200/JCO.19.03011. Epub 2019 Dec 20.
10
getITD for FLT3-ITD-based MRD monitoring in AML.获取用于急性髓系白血病中基于FLT3-ITD的微小残留病监测的ITD。
Leukemia. 2019 Oct;33(10):2535-2539. doi: 10.1038/s41375-019-0483-z. Epub 2019 May 14.